# Revalia Bio

**Canonical:** https://apis.io/providers/revalia-bio/  
**Website:** https://revaliabio.com/  
**APIs profiled:** 0

Revalia Bio transforms donated, non-transplantable human organs and tissues into high-fidelity biological datasets, using AI to accelerate drug and device development. The company has built "The Human Data Stack" — infrastructure spanning data generation, ingestion, integration, interpretation, and delivery of decision-ready clinical insights for pharma, biotech, healthcare, and regulatory customers. Applications include safety signal detection, dose and target selection, patient selection, and mechanism-of-action studies. Founded by Greg Tietjen (CEO) and Jenna DiRito (COO), it generated first revenue in 2023 and raised seed funding in 2024. Backed by Sierra Ventures. As of this enrichment pass Revalia Bio publishes no public developer portal, API, SDK, or technical surface — it is a B2B research-services company, not a developer platform.

## Kin Score — 9.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Revalia Bio Domain Security** — TLSv1.3

## Tags

Company, Biotech, Artificial Intelligence, Drug Development, Medical Devices, Clinical Data, Life Sciences, Translational Science

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/revalia-bio/). Scores are computed from the provider's own public artifacts under a published rubric.